Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
Chen PM, Ohno M, Hiwasa T, Nishi K, Saijo S, Sakamoto J, Morita Y, Matsuda S, Watanabe S, Kuwabara Y, Ono K, Imai M, Inoue K, Murai T, Inada T, Tanaka M, Kita T, Kimura T, Nishi E.
Chen PM, et al. Among authors: kuwabara y.
Int J Cardiol. 2017 Sep 15;243:1-8. doi: 10.1016/j.ijcard.2017.04.047.
Int J Cardiol. 2017.
PMID: 28747015